Chantilly Health & Wellness

ARTEMISIA ANNUA


Artemisia Annua has been extracted and purified from the Artemesia annua L. (wormwood) plant and contains, among its constituent compounds, a sesquiterpene lactone which is responsible for its anti-tumor actions. Records show that Artemisia itself has been used in China (and in the Orient) for thousands of years to treat many types of illness. In 1971, Artemisia Annua was chemically identified and isolated and was shown to be the active component against Malaria(1). More recently, research performed by International scientists (i.e., Drs. Henry Lai and N.P. Singh of the University of Washington in Seattle), has shown Artemisia Annua to be selectively toxic to abnormal cells. Consequently, patients from all over the world are using this phenomenal Abnormal-Cell-Growth-fighting neutraceutical, many under the supervision of physicians, (and many in conjunction with chemotherapy and/or radiation), with numerous life-saving results.

Description

In 1971, Artemisia Annua was chemically identified and isolated and was shown to be the active component against Malaria(1). More recently, research performed by International scientists (i.e., Drs. Henry Lai and N.P. Singh of the University of Washington in Seattle), has shown Artemisia Annua to be selectively toxic to abnormal cell growth cells. Consequently, patients from all over the world are using this phenomenal abnl cell-fighting neutraceutical, many under the supervision of physicians, (and many in conjunction with chemotherapy and/or radiation), with numerous life-saving results. The clinical applications of Artemisia Annua for the use in Abnormal-Cell-Growth treatment/therapy could be one of the most important and influential discoveries of modern, integrative medicine.Artemisia Annua has been extracted and purified from the Artemesia annua L. (wormwood) plant and contains, among its constituent compounds, a sesquiterpene lactone which is responsible for its abnormal cell growth actions.
Artemisia Annua is a lactone compound which contains two (2) oxygen atoms linked together; this is called an endoperoxide bridge which is essential for its anti-abnormal growth cell activity. All cells require iron in order to divide and function, but rapidly dividing abnormal cells require significantly higher iron concentrations to survive than normal, healthy cells do. Since cancer is characterized by out-of-control cellular division, cancer cells have exceedingly higher iron concentrations than do normal cells. When Artemisia Annua or its derivatives come into contact with iron, a chemical reaction takes place which creates newly formed charged particals (ions) called free radicals. These powerful free radicals attack and bind with cellular membranes, killing these cells (which are primarily abnormal growth cells) by causing them micromolecular damage. It should also be noted that, compared to normal cells, abnormal growth cells sequester relatively large amounts of iron mainly in the form of holotransferrin. Artemisia Annua has been shown to cause rapid, as well as extensive, damage and death in abnormal growth cells while exhibiting relatively low toxicity in healthy, normal cells (2).

In the laboratory at the University of Washington, Dr. Henry Lai showed that Artemisia Annua killed virtually all human breast abnormal growth cells exposed to it in the test tube within 16 hours. At the same time, nearly all of the normal, healthy cells exposed to Artemisia Annua over the 16 hours were still viable (alive). Lai and his researchers also reported that a dog with a type of bone abnormal growth cells, so severe that it was unable to walk across the lab, made a complete recovery within five (5) days of receiving Artemisia Annua treatment. The x-rays on this animal revealed that the abnormal growth "had basically disappeared". It is also imperative to note that, on the surfaces of abnormal growth cells there are significantly more transferrin receptors; these are cellular pathways that allow iron to enter the cell. According to Lai, in the case of breast malignancy, (for instance),abnormal growth cells here have five (5) to fifteen (15) times more transferrin receptors on their surfaces than do the normal, healthy breast cells. The iron/AGC relationship is well supported scientifically, as there is a wealth of research which links iron and ACG together. One study, for example, showed that three (3) times as much iron could be extracted from malignant breast tissue than from benign tissue, and these breast AGC cells which were studied here, were also resistant to radiation. Thus, in severe and critical cases, the supplementation of high doses of iron may cause a more powerful attack of Artemisia Annua on these iron-loving abnormal growth cells, weakening them, and making them less resistant (or more suseptable) to radiotherapy. Lai stated that this type of approach might work for abnormal growth cell that are resistant to conventional therapy (3). What is frequently observed is that the more aggressive abnormal growth cell such as pancreatic and acute leukemia, which are characterized by more rapid cellular division and thus higher iron concentrations, respond even better to ART than do less aggressive abnormal growth cells. Lai also noted that in a seperate study, ART therapy eliminated leukemia cells in the test tube within eight (8) hours (4).

When Artemisia Annua was tested on drug sensitive (H69) and multi-drug resistant (H69VP) Small-Cell Lung Carcinoma Cells (SCLC), which were injected with transferrin in order to raise the iron concentration levels, it was found that the cytotoxicity of Artemisia Annua for H69VP cells was ten (10) times lower than for H69 cells. Small-Cell Lung AGC is an extremely aggressive type of lung malignancy that carries with it a very poor long-term prognosis, and in many instances, more drastic (as well as aggressive) therapeutic measures are required. From these studies it is concluded that Artemisia Annua could be used in conjunction with transferrin in drug-resistant SCLC (5). Researchers have also shown that certain modified Artemisia Annua derivatives (containing cyano and aryl groups) are very effective in destroying highly resistant types of leukemia and human lung carcinoma cells (6). In various studies, ART related endoperoxides (see reference #2) also exhibited a positive apoptosis/ability to destroy Ehrlich Ascites Tumor cells (EAT). These tests confirmed that Artemisia Annua and it's derivatives kill EAT cells, with the Artemisia Annua derivatives showing greater efficacy at killing these cells than the mother compound (7).

Artemisia Annua has actually been examined for its activity against fifty five (55) Abnormal Growth cell lines. Over the many years that Artemisia Annua has been researched, it was found to be most active against abnormal growth cells of the blood, colon, skin, breast, prostate, renal (kidney), and of the central nervous system. It has also been reported that Artemisia Annua's effectiveness is comparable with numerous standard drugs and chemotherapeudic agents used to combat abnormal growth cells (8).
The encouraging results found from the numerous studies, combined with its low toxicity, make Artemisia Annua a powerful and effective neutraceutical with incredible promise against many forms of this life-threatening dysfunctions.

                                                                               Buy Artemisia Annua Now

*None of the statements above have been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease.


Home
Shop On-line
Enzymes Info
Protease
Serra-Enzymes
Serra-Natto
Celluzyme
VBF-3
Mitochondrial Activator
Artemisia Annua
Meadowsweet
Hyaluronic Acid
Prena
Contact Us
News
Brochures